1. Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor

   • Lucinda H. Elliott
   • William H. Brooks
   • Thomas L. Roszman

   Laboratory Investigation Pages: 1 - 7

2. Intraneoplastic application of metrizamide containing liposomes: kinetic studies with computed tomography

   • Berndt Wowra
   • Karsten Cremer
   • W. Jens Zeller

   Laboratory Investigation Pages: 9 - 18

3. Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay

   • Joseph P. Jordan
   • Christopher M. Hand
   • Perry Black

   Laboratory Investigation Pages: 19 - 35

4. P-glycoprotein expression in brain tumors

   • John W. Henson
   • Carlos Cordon-Cardo
   • Jerome B. Posner

   Laboratory Investigation Pages: 37 - 43

5. Childhood brain tumors that occupy more than one compartment at presentation

   • F. H. Gilles
   • A. Leviton
   • L. B. Rorke

   Clinical Study Pages: 45 - 56

6. Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy

   • Ammar Hayani
   • Donald H. Mahoney Jr.
   • Linda D. Taylor

   Clinical study Pages: 57 - 62

7. Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma

   • D. S. Fulton
   • R. C. Urtasun
   • M. Feldstein

   Clinical study Pages: 63 - 72

8. Combined intra-arterial chemotherapy followed by radiation in astrocytomas

   • Kjell Watne
   • Einar Hannisdal
   • Henry Hirschberg

   Clinical Study Pages: 73 - 80

9. Metabolic changes of glioma following chemotherapy: an experimental study using four PET tracers

   • Kiyotaka Sato
   • Motonobu Kameyama
   • Takashi Yoshimoto

   Clinical Study Pages: 81 - 89